Trabectedin for recurrent WHO grade 2 or 3 meningiomas-paving the road for new opportunities. Alvarez-Breckenridge CA, Cahill DP, Brastianos PK. Neuro Oncol 2022 Jan 31. pii: 6518099. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Alvarez-Breckenridge CA, Cahill DP, Brastianos PK. Trabectedin for recurrent WHO grade 2 or 3 meningiomas-paving the road for new opportunities. Neuro Oncol 2022 Jan 31. pii: 6518099. doi: 10.1093.
PMID: 35100424